# axcount Generika GmbH

Company profile · SME (from the award notice)

- Legal form: GmbH
- Seat: Friedrichsdorf, Germany

Based on the notices and sources Inteliwert covers; not a complete record. Last checked 1 April 2026.

## Identifiers

- Register entry: HRB 12097

As the covered sources state them.

## Track record in public tenders

Awards in the covered notices over the last 36 months, per CPV division.

| CPV division | Awards | Award value (excl. VAT) | Buyers | Repeat buyers | First award | Last award |
| --- | ---: | ---: | ---: | ---: | --- | --- |
| 33 Medical equipments, pharmaceuticals and personal care products | 1 | — | 1 | 0 | 1 April 2026 | 1 April 2026 |

Based on the notices and sources Inteliwert covers; not a complete record.

### Awards

- [Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Rivaroxaban, ATC B01AF01 für die Zeit 01.04.2026 - 30.06.2026](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi)  
  Buyer: DAK-Gesundheit · Awarded: 1 April 2026 · CPV 33600000

## Certifications and prequalification

No certification or prequalification found in the covered sources.

A certification missing here is unknown, not absent.

## Website and LinkedIn

Not found in the indexed notices.

## Open tenders that might fit

*Possible match based on public information*

Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances.

- [Vergabe der stationären Arzneimittelversorgung](https://inteliwert.com/tender/opp_VXFM6YM84V0PQA2E4KXWHWVNAC/vergabe-der-stationaeren-arzneimittelversorgung)  
  Open · SME (from the award notice) · New to public tenders · Buyer: varisano Klinikum Frankfurt Höchst GmbH · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/ca3897fc-d586-446b-be24-5f1acf0271c2), Last checked 9 Nov 2026, 11:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-04-01): [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026
  - Seat in the same region as the place of performance: [Evidence](https://inteliwert.com/company/org_M1SJRQYHS95MVX4KVWS7A9WRJE), checked 9 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026
- [Rahmenvereinbarung über Reagenzienleasing für die immunhämatologische Diagnostik](https://inteliwert.com/tender/opp_C8F68P16TPAHA8TFFWTXRZPJEX/rahmenvereinbarung-ueber-reagenzienleasing-fuer-die-immunhaematologische-diagnos)  
  Open · SME (from the award notice) · New to public tenders · Buyer: Labor Berlin - Charité Vivantes GmbH · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/10c5eb36-82fe-47ce-96ab-7ccfa5e631c2), Last checked 8 Nov 2026, 13:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-04-01): [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 8 Nov 2026
  - Seat in the same region as the place of performance: [Evidence](https://inteliwert.com/company/org_M1SJRQYHS95MVX4KVWS7A9WRJE), checked 8 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 8 Nov 2026
- [Open-House-Rabattverträge 2024-09](https://inteliwert.com/tender/opp_TS0XMR00JPEWYKXHMTBPQ0SC8M/open-house-rabattvertraege-2024-09)  
  Open · SME (from the award notice) · New to public tenders · Buyer: Techniker Krankenkasse · Deadline: 31 Aug 2028, 23:58 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/99383ac4-92cc-47be-b825-2beeb378d01b), Last checked 9 Nov 2026, 11:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-04-01): [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_M1SJRQYHS95MVX4KVWS7A9WRJE), checked 9 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026
- [Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 SGB V zu biosimilaren Wirkstoffen](https://inteliwert.com/tender/opp_9831TS7NMD60N0S4D8TC4FE68A/abschluss-nicht-exklusiver-rabattvereinbarung-nach-130a-abs-8-sgb-v-zu-biosimila)  
  Open · SME (from the award notice) · New to public tenders · Buyer: GWQ ServicePlus AG · Deadline: 10 Aug 2027, 10:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/3e870a8c-b136-42cc-9309-bbebec6b8523), Last checked 9 Nov 2026, 16:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-04-01): [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_M1SJRQYHS95MVX4KVWS7A9WRJE), checked 9 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026
- [Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Epinephrin (ATC-Code nach WHO: C01CA24) in der Darr. Fertigspritze/-pen](https://inteliwert.com/tender/opp_G1FR72NM9VX7BHH7XGXRC5KD6V/abschluss-nicht-exkl-arzneimittel-rabattvereinb-nach-130a-abs-8-sgb-v-im-wege-ei)  
  Open · SME (from the award notice) · New to public tenders · Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen · Deadline: 30 Sept 2027, 23:58 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/7e5f2207-2bba-49e8-bfc8-e0a347818633), Last checked 9 Nov 2026, 16:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-04-01): [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_M1SJRQYHS95MVX4KVWS7A9WRJE), checked 9 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026
- [Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Epinephrin (ATC-Code nach WHO: C01CA24) in der Darreichung Nasenspray](https://inteliwert.com/tender/opp_3D8YNR13YHJW8XR2SV424QRCKE/abschluss-nicht-exkl-arzneimittel-rabattvereinb-nach-130a-abs-8-sgb-v-im-wege-ei)  
  Open · SME (from the award notice) · New to public tenders · Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen · Deadline: 30 Sept 2027, 23:58 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/423e0326-3f32-4bb4-8ff8-0c813de5738e), Last checked 9 Nov 2026, 16:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-04-01): [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_M1SJRQYHS95MVX4KVWS7A9WRJE), checked 9 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026
- [Arzneimittel mit dem Wirkstoff Tocilizumab (ATC: L04AC07)](https://inteliwert.com/tender/opp_51R5KQN69DAZX88KVC7KW2S74V/arzneimittel-mit-dem-wirkstoff-tocilizumab-atc-l04ac07)  
  Open · SME (from the award notice) · New to public tenders · Buyer: AOK Sachsen - Anhalt · Deadline: 31 Jul 2028, 00:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/36e50079-bf42-4e5c-9149-aae360b5e49f), Last checked 9 Nov 2026, 13:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-04-01): [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_M1SJRQYHS95MVX4KVWS7A9WRJE), checked 9 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026
- [Arzneimittel mit dem Wirkstoff Golimumab (ATC: L04AB06)](https://inteliwert.com/tender/opp_3H584JP5294427YX17F541ZK0Y/arzneimittel-mit-dem-wirkstoff-golimumab-atc-l04ab06)  
  Open · SME (from the award notice) · New to public tenders · Buyer: AOK Sachsen - Anhalt · Deadline: 31 Jul 2028, 00:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/024ae079-193f-4922-af39-efc23dfe5e70), Last checked 9 Nov 2026, 13:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-04-01): [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_M1SJRQYHS95MVX4KVWS7A9WRJE), checked 9 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026
- [Arzneimittelverträge mit Beitrittsoption](https://inteliwert.com/tender/opp_ZRCHA0D7RV1FXHV0ZGJ7F015SG/arzneimittelvertraege-mit-beitrittsoption)  
  Open · SME (from the award notice) · New to public tenders · Buyer: BARMER Beschaffung und Vergabe · Deadline: 1 Nov 2027, 12:00 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/d1305fd9-8e8c-4550-ad99-a30b2bb14d16), Last checked 8 Nov 2026, 16:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-04-01): [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 8 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_M1SJRQYHS95MVX4KVWS7A9WRJE), checked 8 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 8 Nov 2026
- [Arzneimittelverträge mit Beitrittsoption](https://inteliwert.com/tender/opp_DGM8H91ZA3P1C23NX55E16662G/arzneimittelvertraege-mit-beitrittsoption)  
  Open · SME (from the award notice) · New to public tenders · Buyer: BARMER Beschaffung und Vergabe · Deadline: 1 Feb 2028, 07:04 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/eff32508-c459-43f7-96fa-5caeab05b965), Last checked 8 Nov 2026, 18:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-04-01): [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 8 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_M1SJRQYHS95MVX4KVWS7A9WRJE), checked 8 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 8 Nov 2026

## Is this your company?

Send corrections, or ask us to remove the profile, to <hello@inteliwert.com>. You can also ask that the company never be tagged on LinkedIn.

## About this profile

Each fact on this page shows its source: a public notice, an open-data register (GLEIF, Wikidata) or the company’s own website. Inteliwert does not rate companies and does not judge eligibility, fit or chances.

**Based on the notices and sources Inteliwert covers; not a complete record.** Last checked 1 April 2026.

---

Page: https://inteliwert.com/company/org_M1SJRQYHS95MVX4KVWS7A9WRJE/axcount-generika-gmbh

Inteliwert is a product of Bandpey GmbH, an international data and AI software company in Munich, Germany, founded and led by Roozbeh Bandpey. Bandpey's products: Facthory, Emolysis, Copolly and Inteliwert.

Inteliwert on LinkedIn: https://www.linkedin.com/company/intelliwert, GitHub: https://github.com/inteliwertai.